Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Lipophilic camptothecin derivatives with favorable profile of activity, toxicity

May 25, 2000

AstraZeneca develops new treatments for cancer, rheumatoid arthritis, etc.

May 25, 2000

Oregon State U. researchers disclose curacin A derivatives with improved stability

May 25, 2000

TNP-470 delays gastric ulcer healing in rats

May 25, 2000

GTI-2040 phase I/II trial on target for completion by year-end

May 25, 2000

Proteasome inhibitor MG-132 endowed with antineoplastic activity

May 25, 2000

DDW presentations support efficacy of exisulind in FAP and related conditions

May 24, 2000

Inhibitors of cyclin-dependent kinases claimed by DuPont for cancer

May 24, 2000

Proteasome inhibitors and their use presented by Max Planck

May 24, 2000

Marine sponges yield new biologically active discorhabdin compounds

May 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...